Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Trudeau

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Oncotarget|December 17, 2021
Radiomics in predicting recurrence for patients with locally advanced breast cancer using quantitative ultrasoundArchya Dasgupta, Divya Bhardwaj, Daniel DiCenzo, et al.
Journal of Imaging|April 25, 2025
Validation of Quantitative Ultrasound and Texture Derivative Analyses-Based Model for Upfront Prediction of Neoadjuvant Chemotherapy Response in Breast CancerAdrian Wai Chan, Lakshmanan Sannachi, Daniel Moore-Palhares, et al.
Translational Oncology|February 19, 2013
Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastographyOmar Falou, Ali Sadeghi-Naini, Sameera Prematilake, et al.
Cancers|August 14, 2025
Validation of a Quantitative Ultrasound Texture Analysis Model for Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: A Prospective Serial Imaging StudyDaniel Moore-Palhares, Lakshmanan Sannachi, Adrian Wai Chan, et al.
Cancer Research|April 3, 2008
Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international studyShiyu Zhang, Catherine M Phelan, Phil Zhang, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) CollaborationPam Takhar, Marc Geirnaert, Scott Gavura, et al.
Plos One|July 28, 2020
Quantitative ultrasound radiomics for therapy response monitoring in patients with locally advanced breast cancer: Multi-institutional study resultsKarina Quiaoit, Daniel DiCenzo, Kashuf Fatima, et al.
Cancer Medicine|July 1, 2020
Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi-institutional studyDaniel DiCenzo, Karina Quiaoit, Kashuf Fatima, et al.
Plos Medicine|May 17, 2024
Radiation enhancement using focussed ultrasound-stimulated microbubbles for breast cancer: A Phase 1 clinical trialDaniel Moore-Palhares, Archya Dasgupta, Murtuza Saifuddin, et al.
JAMA Network Open|August 2, 2022
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, CanadaSteven Habbous, Xiaochen Tai, Jaclyn M Beca, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Oncotarget|December 17, 2021
Radiomics in predicting recurrence for patients with locally advanced breast cancer using quantitative ultrasoundArchya Dasgupta, Divya Bhardwaj, Daniel DiCenzo, et al.
Journal of Imaging|April 25, 2025
Validation of Quantitative Ultrasound and Texture Derivative Analyses-Based Model for Upfront Prediction of Neoadjuvant Chemotherapy Response in Breast CancerAdrian Wai Chan, Lakshmanan Sannachi, Daniel Moore-Palhares, et al.
Translational Oncology|February 19, 2013
Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastographyOmar Falou, Ali Sadeghi-Naini, Sameera Prematilake, et al.
Cancers|August 14, 2025
Validation of a Quantitative Ultrasound Texture Analysis Model for Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: A Prospective Serial Imaging StudyDaniel Moore-Palhares, Lakshmanan Sannachi, Adrian Wai Chan, et al.
Cancer Research|April 3, 2008
Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international studyShiyu Zhang, Catherine M Phelan, Phil Zhang, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) CollaborationPam Takhar, Marc Geirnaert, Scott Gavura, et al.
Plos One|July 28, 2020
Quantitative ultrasound radiomics for therapy response monitoring in patients with locally advanced breast cancer: Multi-institutional study resultsKarina Quiaoit, Daniel DiCenzo, Kashuf Fatima, et al.
Cancer Medicine|July 1, 2020
Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi-institutional studyDaniel DiCenzo, Karina Quiaoit, Kashuf Fatima, et al.
Plos Medicine|May 17, 2024
Radiation enhancement using focussed ultrasound-stimulated microbubbles for breast cancer: A Phase 1 clinical trialDaniel Moore-Palhares, Archya Dasgupta, Murtuza Saifuddin, et al.
JAMA Network Open|August 2, 2022
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, CanadaSteven Habbous, Xiaochen Tai, Jaclyn M Beca, et al.
Pageof 11